DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/6drhjn/molecular) has announced the addition of the "Molecular Diagnostics Market by Application, Technology, End User, Product - Forecast to 2020" report to their offering.
The molecular diagnostics market is expected to grow at a CAGR of 9.3% to reach USD 9,333.8 Million by 2020
The major factors driving this market are high prevalence of infectious diseases and various types of cancer; increasing awareness and acceptance of personalized medicine and companion diagnostics; development of bio-markers; and advancements in molecular techniques, proteomics, and reformations in the reimbursement system.
However, increased cost of molecular diagnostics tools, dearth of skilled labor to handle new and complex platforms, and the complex regulatory framework are the major factors restraining the growth of the molecular diagnostics market.
In this report, the molecular diagnostics market is broadly segmented on the basis of technologies, applications, products & services, and end users.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
6 Molecular Diagnostics Market, by Application
7 Molecular Diagnostics Market, by Technology
8 Molecular Diagnostics Market, by Products and Services
9 Molecular Diagnostics Market, by End User
10 Molecular Diagnostic Market, by Region
11 Competitive Landscape
12 Company Profiles
- Abbott Laboratories
- Beckman Coulter Inc. (Wholly Owned Subsidiary of Danaher Corporation)
- Becton, Dickinson and Company
- Biomérieux Sa
- Cepheid Inc.
- Grifols
- Hologic, Inc.
- Qiagen N.V.
- Roche Diagnostics
-
Siemens Healthcare
For more information visit http://www.researchandmarkets.com/research/6drhjn/molecular
